Markovic-Plese S - Search Results

1

A role of IL-1R1 signaling in the differentiation of Th17 cells and the development of autoimmune diseases.

Sha Y, Markovic-Plese S. Sha Y, et al. Self Nonself. 2011 Jan;2(1):35-42. doi: 10.4161/self.2.1.15639. Epub 2011 Jan 1. Self Nonself. 2011. PMID: 21776333 Free PMC article.

2

IFN-beta inhibits human Th17 cell differentiation.

Ramgolam VS, Sha Y, Jin J, Zhang X, Markovic-Plese S. Ramgolam VS, et al. J Immunol. 2009 Oct 15;183(8):5418-27. doi: 10.4049/jimmunol.0803227. Epub 2009 Sep 25. J Immunol. 2009. PMID: 19783688

3

Interferon-beta inhibits Th17 cell differentiation in patients with multiple sclerosis.

Ramgolam VS, Markovic-Plese S. Ramgolam VS, et al. Endocr Metab Immune Disord Drug Targets. 2010 Jun;10(2):161-7. doi: 10.2174/187153010791213029. Endocr Metab Immune Disord Drug Targets. 2010. PMID: 20384573 Review.

4

B cells as a therapeutic target for IFN-β in relapsing-remitting multiple sclerosis.

Ramgolam VS, Sha Y, Marcus KL, Choudhary N, Troiani L, Chopra M, Markovic-Plese S. Ramgolam VS, et al. J Immunol. 2011 Apr 1;186(7):4518-26. doi: 10.4049/jimmunol.1000271. Epub 2011 Mar 2. J Immunol. 2011. PMID: 21368231

5

Simvastatin inhibits IFN regulatory factor 4 expression and Th17 cell differentiation in CD4+ T cells derived from patients with multiple sclerosis.

Zhang X, Tao Y, Troiani L, Markovic-Plese S. Zhang X, et al. J Immunol. 2011 Sep 15;187(6):3431-7. doi: 10.4049/jimmunol.1100580. Epub 2011 Aug 19. J Immunol. 2011. PMID: 21856936

6

Activated IL-1RI Signaling Pathway Induces Th17 Cell Differentiation via Interferon Regulatory Factor 4 Signaling in Patients with Relapsing-Remitting Multiple Sclerosis.

Sha Y, Markovic-Plese S. Sha Y, et al. Front Immunol. 2016 Nov 29;7:543. doi: 10.3389/fimmu.2016.00543. eCollection 2016. Front Immunol. 2016. PMID: 27965670 Free PMC article.

7

IL-11 Induces Encephalitogenic Th17 Cells in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis.

Zhang X, Kiapour N, Kapoor S, Khan T, Thamilarasan M, Tao Y, Cohen S, Miller R, Sobel RA, Markovic-Plese S. Zhang X, et al. Among authors: markovic plese s. J Immunol. 2019 Sep 1;203(5):1142-1150. doi: 10.4049/jimmunol.1900311. Epub 2019 Jul 24. J Immunol. 2019. PMID: 31341075 Free PMC article.

8

The initiation of the autoimmune response in multiple sclerosis.

Markovic-Plese S, Pinilla C, Martin R. Markovic-Plese S, et al. Clin Neurol Neurosurg. 2004 Jun;106(3):218-22. doi: 10.1016/j.clineuro.2004.02.018. Clin Neurol Neurosurg. 2004. PMID: 15177771 Review.

9

Degenerate TCR recognition and dual DR2 restriction of autoreactive T cells: implications for the initiation of the autoimmune response in multiple sclerosis.

Zhang X, Tang Y, Sujkowska D, Wang J, Ramgolam V, Sospedra M, Adams J, Martin R, Pinilla C, Markovic-Plese S. Zhang X, et al. Eur J Immunol. 2008 May;38(5):1297-309. doi: 10.1002/eji.200737519. Eur J Immunol. 2008. PMID: 18412170 Free article.

10

Simvastatin inhibits IL-17 secretion by targeting multiple IL-17-regulatory cytokines and by inhibiting the expression of IL-17 transcription factor RORC in CD4+ lymphocytes.

Zhang X, Jin J, Peng X, Ramgolam VS, Markovic-Plese S. Zhang X, et al. J Immunol. 2008 May 15;180(10):6988-96. doi: 10.4049/jimmunol.180.10.6988. J Immunol. 2008. PMID: 18453621

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

70 results

Search Page

Filters